{"result": "(\"entity\"<|>PACIENTE<|>PERSON<|>The patient described in the text is an individual with sexual differentiation disorders, potentially affected by various genetic conditions.)\n##\n(\"entity\"<|>CROMOSOMA X<|>PERSON<|>Chromosome X is one of the two sex chromosomes in humans, involved in the genetic makeup and differentiation of sexual characteristics.)\n##\n(\"entity\"<|>CROMOSOMA Y<|>PERSON<|>Chromosome Y is one of the two sex chromosomes in humans, crucial for male sex determination and development.)\n##\n(\"entity\"<|>ALTERACIONES DE LA DIFERENCIACIÓN SEXUAL<|>EVENT<|>Alterations in sexual differentiation refer to various congenital conditions that lead to discrepancies in chromosomal, gonadal, and phenotypic sexual characteristics.)\n##\n(\"entity\"<|>GEN SRY-POSITIVOS<|>PERSON<|>Individuals who are SRY-positive have the SRY gene, which is associated with male sexual differentiation.)\n##\n(\"entity\"<|>GEN SRY-NEGATIVOS<|>PERSON<|>Individuals who are SRY-negative lack the SRY gene, which can lead to different sexual development outcomes.)\n##\n(\"relationship\"<|>PACIENTE<|>ALTERACIONES DE LA DIFERENCIACIÓN SEXUAL<|>The patient is described as having alterations in sexual differentiation, indicating a direct relationship<|>9)\n##\n(\"relationship\"<|>CROMOSOMA X<|>CROMOSOMA Y<|>The interaction between chromosome X and Y is fundamental in determining male and female characteristics<|>8)\n##\n(\"relationship\"<|>GEN SRY<|>GEN SRY-POSITIVOS<|>Individuals who are SRY-positive possess the SRY gene, which is essential for male differentiation<|>9)\n##\n(\"relationship\"<|>GEN SRY<|>GEN SRY-NEGATIVOS<|>Individuals who are SRY-negative lack the SRY gene, leading to different sexual development outcomes<|>7)\n##\n(\"relationship\"<|>ALTERACIONES DE LA DIFERENCIACIÓN SEXUAL<|>MICROCEFALIA<|>Alterations in sexual differentiation can be associated with microcephaly as a developmental issue<|>5)\n##\n(\"relationship\"<|>ALTERACIONES DE LA DIFERENCIACIÓN SEXUAL<|>CARDIOPATÍAS<|>Alterations in sexual differentiation can also be linked to various cardiopathies<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: diferenciación sexual o desarrollo sexual diferente (DSD) engloban un\n                  el paciente descrito.                                                                                  amplio espectro de alteraciones congénitas que conllevan discordancias entre los criterios\n              B. En estos pacientes, el gen SRY habitualmente se transloca a un cromosoma X durante                      cromosómico, gonadal y fenotípico que definen la diferenciación sexual.\n                  la profase de la primera división meiótica paterna.                                                    Las alteraciones de la diferenciación sexual 46,XX no sindrómicas se caracterizan por\n              C. Los no portadores de SRY (el otro 50% de los pacientes) pueden haber sufrido una                        un fenotipo masculino con cariotipo femenino, presencia de testículos, azoospermia y\n                  mutación en un autosoma o en un cromosoma X con el resultado de una secuencia                          ausencia de estructuras müllerianas, lo que ocurre en 3,5-4,7 de cada 100.000 recién na-\n                  genética muy diferente al SRY.                                                                         cidos varones.\n              D.  Los no portadores de SRY también pueden presentar un mosaicismo 45,X/47,XXY.                           A diferencia del síndrome de Klinefelter (47,XXY), la característica que define el síndrome es el\n              En los varones 46,XX no portadores del gen SRY, a diferencia del paciente descrito,                        desarrollo testic lar en individuos con 46 cromosomas, dos de ellos X y sin presencia de cromo-\n       28                                                                                                                soma Y normal en la mayoría de sus líneas celulares. No obstante, el paciente ha de tener ma-\n              es cierto que:                                                                                             terial procedente del gen Y más o menos evidente, ya que el gen SRY (región Y determinante\n              A. Presentan ginecomastia de manera constante.                                                             del sexo) está involucrado en la diferenciación de las células de Sertoli y en el desarrollo de los\n              B. Pueden presentar genitales atípicos.                                                                    testículos. En la profase de la primera división meiótica paterna de varones 46,XX con alteraciones\n                                                                                                                         de la diferenciación sexual surgen translocaciones del gen SRY del cromosoma Y al cromosoma\n              C. Pueden presentar microcefalia y cardiopatías.                                                           X en más del 80% de pacientes (gen SRY-positivos). Suele tratarse de casos aislados, pero tam-\n              D.  Todas las respuestas anteriores son ciertas.                                                           bién hay descritos casos hereditarios autosómicos dominantes. Para confirmar el diagnóstico se\n                                                                                                                         puede determinar el gen SRY (sex-determining region of the Y chromosome).\n       29     Señale la opción correcta en relación con el tratamiento sustitutivo con testosterona:                     En el resto de varones SRY-negativos, el mosaicismo del gen SRY podría estar oculto. Se\n              A. Los derivados 17α-alquilados de testosterona por vía oral son de elección en pacientes                  ha sugerido un patrón de herencia autosómico recesivo. La patogenia de la enfermedad en\n                  ancianos por su baja potencia.                                                                         pacientes SRY negativos también se ha asociado con la sobreexpresión de genes (SOX9,\n              B. Entre los ésteres de testosterona para administración parenteral, el enantato suele                     SOX3, etc.) responsables del desarrollo de genitales masculinos o la inadecuada expresión\n                  administrarse por vía subcutánea y el cipionato por vía intramuscular.                                 génica (WNT4, RSPO1, etc.) responsable del desarrollo de los genitales femeninos. En algún\n              C. El undecanoato de testosterona 1M puede ocasionar tos, microembolias grasas                             caso se han descrito mutaciones del gen RSPO1, que codifica la R-espondina 1 en pacien-\n                  pulmonares y reacciones anafilácticas.                                                                 tes con hiperqueratosis palmoplantar y carcinoma de células escamosas, que es un factor\n              D.  La testosterona transdérmica, en gel o parches, a dosis bajas tiene la indicación                      represor del desarrollo testicular.\n                  específica para la potenciación de caracteres sexuales secundarios en ausencia de un                   Aproximadamente el 85% de los pacientes con desarrollo sexual diferente (DSD) no sindró-\n                  hipogonadismo analítico absoluto.                                                                      mico testicular 46,XX son diagnosticados después de la pubertad. Estos pacientes presen-\n\n\n\n350                                                                                                                                                                                                                              351\n---\n                                                                                                                                            GÓNADAS,              SÍNDROME POLIGLANDULAR                                               6\n                                                                                                                                                               AUTOINMUNE                   Y MISCELÁNEA\n\n\n\n     tan vello púbico      y tamaño del pene normales, pero             testículos pequeños, ginecomastia y           Las opciones de fertilidad se limitan a la inseminación artificial mediante\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>GEN SRY<|>PERSON<|>Gen SRY is a gene located on the Y chromosome that plays a crucial role in sexual differentiation and the development of male characteristics.)\n##\n(\"entity\"<|>SÍNDROME DE KLINEFELTER<|>EVENT<|>Klinefelter syndrome is a genetic condition in males characterized by the presence of an extra X chromosome, leading to various physical and developmental traits.)\n##\n(\"entity\"<|>MOSAICISMO 45,X/47,XXY<|>EVENT<|>Mosaicism 45,X/47,XXY refers to a genetic condition where some cells have a normal male karyotype while others have an abnormal karyotype, affecting sexual development.)\n##\n(\"entity\"<|>TESTOSTERONA<|>PERSON<|>Testosterone is a hormone that plays a key role in the development of male physical characteristics and is used in hormone replacement therapy.)\n##\n(\"entity\"<|>GINECOMASTIA<|>EVENT<|>Gynecomastia is the enlargement of breast tissue in males, often associated with hormonal imbalances.)\n##\n(\"entity\"<|>CARDIOPATÍAS<|>EVENT<|>Cardiopathies refer to various heart conditions that can affect individuals with sexual differentiation disorders.)\n##\n(\"entity\"<|>MICROCEFALIA<|>EVENT<|>Microcephaly is a medical condition where a person's head is significantly smaller than expected, often associated with developmental issues.)\n##\n(\"relationship\"<|>GEN SRY<|>SÍNDROME DE KLINEFELTER<|>The presence of the SRY gene is crucial in the development of male characteristics, and its absence or mutation is linked to Klinefelter syndrome<|>8)\n##\n(\"relationship\"<|>GEN SRY<|>MOSAICISMO 45,X/47,XXY<|>The SRY gene's translocation can lead to conditions like mosaicism 45,X/47,XXY, affecting sexual differentiation<|>7)\n##\n(\"relationship\"<|>TESTOSTERONA<|>GINECOMASTIA<|>Testosterone therapy can influence the development of gynecomastia in individuals with hormonal imbalances<|>6)\n##\n(\"relationship\"<|>MICROCEFALIA<|>CARDIOPATÍAS<|>Microcephaly and cardiopathies can be associated with genetic conditions affecting sexual differentiation<|>5)\n<|COMPLETE|>"}]}